BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 1660143)

  • 1. Activation of the erythropoietin receptor promoter by transcription factor GATA-1.
    Zon LI; Youssoufian H; Mather C; Lodish HF; Orkin SH
    Proc Natl Acad Sci U S A; 1991 Dec; 88(23):10638-41. PubMed ID: 1660143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response to erythropoietin in erythroid subclones of the factor-dependent cell line 32D is determined by translocation of the erythropoietin receptor to the cell surface.
    Migliaccio AR; Migliaccio G; D'Andrea A; Baiocchi M; Crotta S; Nicolis S; Ottolenghi S; Adamson JW
    Proc Natl Acad Sci U S A; 1991 Dec; 88(24):11086-90. PubMed ID: 1722318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GATA-1 transactivates erythropoietin receptor gene, and erythropoietin receptor-mediated signals enhance GATA-1 gene expression.
    Chiba T; Ikawa Y; Todokoro K
    Nucleic Acids Res; 1991 Jul; 19(14):3843-8. PubMed ID: 1650452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of transcription of the human erythropoietin receptor gene by proteins binding to GATA-1 and Sp1 motifs.
    Chin K; Oda N; Shen K; Noguchi CT
    Nucleic Acids Res; 1995 Aug; 23(15):3041-9. PubMed ID: 7659529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The gene for erythropoietin receptor is expressed in multipotential hematopoietic and embryonal stem cells: evidence for differentiation stage-specific regulation.
    Heberlein C; Fischer KD; Stoffel M; Nowock J; Ford A; Tessmer U; Stocking C
    Mol Cell Biol; 1992 Apr; 12(4):1815-26. PubMed ID: 1312671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Further characterization of cis-acting regulatory sequences in the genomic locus of the murine erythropoietin receptor: evidence for stage-specific regulation.
    Youssoufian H
    Blood; 1994 Mar; 83(5):1428-35. PubMed ID: 8118044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GATA-1 and erythropoietin receptor genes are highly expressed in erythroleukemia.
    Komatsu N; Kirito K; Izumi T; Eguchi M; Miura Y
    Exp Hematol; 1998 Nov; 26(12):1148-54. PubMed ID: 9808054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transactivation of erythroid transcription factor GATA-1 by a myb-ets-containing retrovirus.
    Aurigemma RE; Blair DG; Ruscetti SK
    J Virol; 1992 May; 66(5):3056-61. PubMed ID: 1560536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythroid-specific activation of the distal (testis) promoter of GATA1 during differentiation of purified normal murine hematopoietic stem cells.
    Migliaccio AR; Migliaccio G; Ashihara E; Moroni E; Giglioni B; Ottolenghi S
    Acta Haematol; 1996; 95(3-4):229-35. PubMed ID: 8677748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of the erythroid Kruppel-like factor (EKLF) gene promoter by the erythroid transcription factor GATA-1.
    Crossley M; Tsang AP; Bieker JJ; Orkin SH
    J Biol Chem; 1994 Jun; 269(22):15440-4. PubMed ID: 8195185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphatidylinositol 3-kinase/Akt induced by erythropoietin renders the erythroid differentiation factor GATA-1 competent for TIMP-1 gene transactivation.
    Kadri Z; Maouche-Chretien L; Rooke HM; Orkin SH; Romeo PH; Mayeux P; Leboulch P; Chretien S
    Mol Cell Biol; 2005 Sep; 25(17):7412-22. PubMed ID: 16107690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional analysis and in vivo footprinting implicate the erythroid transcription factor GATA-1 as a positive regulator of its own promoter.
    Tsai SF; Strauss E; Orkin SH
    Genes Dev; 1991 Jun; 5(6):919-31. PubMed ID: 2044960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of mouse GATA-1 function by the glucocorticoid receptor: possible mechanism of steroid inhibition of erythroleukemia cell differentiation.
    Chang TJ; Scher BM; Waxman S; Scher W
    Mol Endocrinol; 1993 Apr; 7(4):528-42. PubMed ID: 8502237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of GATA-1 and EPO receptor genes by a leukemia-inducing retrovirus.
    Ruscetti SK; Aurigemma RE
    Ann N Y Acad Sci; 1994 Apr; 718():245-54; discussion 254-6. PubMed ID: 8185231
    [No Abstract]   [Full Text] [Related]  

  • 15. Transcriptional and posttranscriptional regulation of the expression of the erythropoietin receptor gene in human erythropoietin-responsive cell lines.
    Migliaccio AR; Jiang Y; Migliaccio G; Nicolis S; Crotta S; Ronchi A; Ottolenghi S; Adamson JW
    Blood; 1993 Dec; 82(12):3760-9. PubMed ID: 8260713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-cycle-dependent regulation of erythropoietin receptor gene.
    Komatsu N; Kirito K; Kashii Y; Furukawa Y; Kikuchi J; Suwabe N; Yamamoto M; Miura Y
    Blood; 1997 Feb; 89(4):1182-8. PubMed ID: 9028940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GATA-and SP1-binding sites are required for the full activity of the tissue-specific promoter of the tal-1 gene.
    Lecointe N; Bernard O; Naert K; Joulin V; Larsen CJ; Romeo PH; Mathieu-Mahul D
    Oncogene; 1994 Sep; 9(9):2623-32. PubMed ID: 8058326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dependence for the proliferative response to erythropoietin on an established erythroid differentiation program in a human hematopoietic cell line, UT-7.
    Nicolis S; Ottolenghi S; Papayannopoulou T; Baiocchi M; Migliaccio G; Adamson J; Migliaccio AR
    Exp Hematol; 1993 May; 21(5):665-70. PubMed ID: 8513868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progressive inactivation of the expression of an erythroid transcriptional factor in GM- and G-CSF-dependent myeloid cell lines.
    Crotta S; Nicolis S; Ronchi A; Ottolenghi S; Ruzzi L; Shimada Y; Migliaccio AR; Migliaccio G
    Nucleic Acids Res; 1990 Dec; 18(23):6863-9. PubMed ID: 1702202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor necrosis factor alpha inhibits erythroid differentiation in human erythropoietin-dependent cells involving p38 MAPK pathway, GATA-1 and FOG-1 downregulation and GATA-2 upregulation.
    Buck I; Morceau F; Cristofanon S; Heintz C; Chateauvieux S; Reuter S; Dicato M; Diederich M
    Biochem Pharmacol; 2008 Nov; 76(10):1229-39. PubMed ID: 18805401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.